VABC Offers Support in Response to Catholic Bishop’s Brain Cancer Diagnosis
Bishop Emeritus John D’Arcy was diagnosed during the holiday season. Voices Against Brain Cancer responds to his fight against brain and lung cancer and offers their support.
New York, N.Y. (PRWEB) January 12, 2013
On January 12, Voices Against Brain Cancer (VABC) responds to retired Catholic Bishop John D´Arcy´s brain and lung cancer diagnosis.
D´Arcy was diagnosed with lung and brain cancer on December 29, according to a recent article from the San Francisco Chronicle, after not feeling well during Christmas with his family. The 80-year-old former Catholic Bishop lives in Fort Wayne, IN however he will begin outpatient treatments in Massachusetts.
In the article, D´Arcy was quoted saying “they kept me overnight – my first night in a hospital since I was born in that same hospital 80 years ago; so, I am ahead of the game thanks to the good Lord.”
Scott Darrohn, a spokesperson for VABC, responds to the news of D´Arcy´s diagnosis, offering support. “We know that brain cancer affects the lives of more than just the people diagnosed; it impacts family and friends as well and John D´Arcy has touched so many lives in his time with the church,” Darrohn said. “We hope he stays strong and fights to make a full recovery.”
Darrohn added that while D´Arcy´s diagnosis is tragic news, he hopes that D´Arcy´s status in the community will help raise cancer awareness and fund research towards a cure for the disease that has claimed so many lives.
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization´s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC’s mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10299042.htm